{"title":"住院老年患者的综合用药和抗胆碱能负担-横断面审计","authors":"J. Ulley, Sakila Sickander, A. Abdelhafiz","doi":"10.59566/ijbs.2018.14036","DOIUrl":null,"url":null,"abstract":"Objectives: To investigate the impact of hospital admission on polypharmacy and anticholinergic burden and explore doctors’ awareness of cognitive side effects of anticholinergics use. Methods:A cross sectional retrospective audit of older patients admitted to a care of elderly ward over three months. We have collected patients’ demographic data, number of medications and anticholinergic burden scale on admission compared to on discharge and investigated doctors’ knowledge about polypharmacy by answering a questionnaire. Results: 100 patients were included. Mean number of medications and anticholinergic burden were significantly higher on discharge compared to admission (9.43 v.8.27, p<0.001 and 1.50 v. 1.30, p<0.01, re4spectively). Seven doctors (25%) had no knowledge of any anticholinergic medications at all. Only 16 (57%) doctors were aware of the negative impact of this class of medications on cognitive function and 22 (79%) doctors felt not at all confident in identifying or reducing anticholinergic prescriptions for inpatients. Conclusion:Hospitalisation results in a significant increase in polypharmacy and anticholinergic burden in older people and doctors’ knowledge of the cognitive risks associated with anticholinergic medications in older people is poor.","PeriodicalId":13852,"journal":{"name":"International Journal of Biomedical Science : IJBS","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit\",\"authors\":\"J. Ulley, Sakila Sickander, A. Abdelhafiz\",\"doi\":\"10.59566/ijbs.2018.14036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: To investigate the impact of hospital admission on polypharmacy and anticholinergic burden and explore doctors’ awareness of cognitive side effects of anticholinergics use. Methods:A cross sectional retrospective audit of older patients admitted to a care of elderly ward over three months. We have collected patients’ demographic data, number of medications and anticholinergic burden scale on admission compared to on discharge and investigated doctors’ knowledge about polypharmacy by answering a questionnaire. Results: 100 patients were included. Mean number of medications and anticholinergic burden were significantly higher on discharge compared to admission (9.43 v.8.27, p<0.001 and 1.50 v. 1.30, p<0.01, re4spectively). Seven doctors (25%) had no knowledge of any anticholinergic medications at all. Only 16 (57%) doctors were aware of the negative impact of this class of medications on cognitive function and 22 (79%) doctors felt not at all confident in identifying or reducing anticholinergic prescriptions for inpatients. Conclusion:Hospitalisation results in a significant increase in polypharmacy and anticholinergic burden in older people and doctors’ knowledge of the cognitive risks associated with anticholinergic medications in older people is poor.\",\"PeriodicalId\":13852,\"journal\":{\"name\":\"International Journal of Biomedical Science : IJBS\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Biomedical Science : IJBS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.59566/ijbs.2018.14036\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biomedical Science : IJBS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59566/ijbs.2018.14036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨住院对多药及抗胆碱能负担的影响,探讨医生对抗胆碱能药物使用认知副作用的认识。方法:对在老年病房住院三个月以上的老年患者进行横断面回顾性审计。我们收集了患者入院时与出院时的人口学数据、用药数量和抗胆碱能负荷量表,并通过问卷调查了医生对多药的了解情况。结果:纳入100例患者。出院时平均用药次数和抗胆碱能负荷显著高于入院时(分别为9.43 vs .8.27, p<0.001和1.50 vs . 1.30, p<0.01)。7名医生(25%)完全不知道任何抗胆碱能药物。只有16名(57%)医生意识到这类药物对认知功能的负面影响,22名(79%)医生对确定或减少住院患者的抗胆碱能药物处方完全没有信心。结论:住院导致老年人多药和抗胆碱能负担明显增加,医生对老年人抗胆碱能药物相关认知风险的认识较差。
Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit
Objectives: To investigate the impact of hospital admission on polypharmacy and anticholinergic burden and explore doctors’ awareness of cognitive side effects of anticholinergics use. Methods:A cross sectional retrospective audit of older patients admitted to a care of elderly ward over three months. We have collected patients’ demographic data, number of medications and anticholinergic burden scale on admission compared to on discharge and investigated doctors’ knowledge about polypharmacy by answering a questionnaire. Results: 100 patients were included. Mean number of medications and anticholinergic burden were significantly higher on discharge compared to admission (9.43 v.8.27, p<0.001 and 1.50 v. 1.30, p<0.01, re4spectively). Seven doctors (25%) had no knowledge of any anticholinergic medications at all. Only 16 (57%) doctors were aware of the negative impact of this class of medications on cognitive function and 22 (79%) doctors felt not at all confident in identifying or reducing anticholinergic prescriptions for inpatients. Conclusion:Hospitalisation results in a significant increase in polypharmacy and anticholinergic burden in older people and doctors’ knowledge of the cognitive risks associated with anticholinergic medications in older people is poor.